| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
24,562 |
16,764 |
$659K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
3,760 |
3,693 |
$520K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,568 |
9,234 |
$417K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,284 |
2,280 |
$179K |
| 95117 |
|
23,575 |
15,670 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,809 |
2,644 |
$153K |
| 95024 |
|
900 |
898 |
$116K |
| J2357 |
Injection, omalizumab, 5 mg |
255 |
190 |
$94K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
602 |
602 |
$61K |
| 94060 |
|
2,612 |
1,766 |
$60K |
| 94010 |
|
3,281 |
2,428 |
$53K |
| 96401 |
|
844 |
706 |
$46K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,186 |
1,851 |
$31K |
| 95115 |
|
2,169 |
1,523 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
351 |
338 |
$11K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
138 |
65 |
$8K |
| 95044 |
|
13 |
13 |
$4K |
| 95076 |
|
34 |
24 |
$3K |
| G0299 |
Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes |
19 |
13 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
30 |
$885.54 |